Pgp9.5 (UCHL-1) (13C4), CF488A conjugate, 0.1mg/mL
Pgp9.5 (UCHL-1) (13C4), CF488A conjugate, 0.1mg/mL thumbnail 1
GTR00933371

Pgp9.5 (UCHL-1) (13C4), CF488A conjugate, 0.1mg/mL

antibody-rabbit-caspase

Description

This MAb reacts with a protein of 20-30 kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1) . Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Synonyms
Gracile Axonal Dystrophy|Neuron Cytoplasmic Protein 9.5|Park5|Parkinson Disease 5|PGP95|Protein Gene Product 9.5|Ubiquitin Carboxyl-terminal Esterase L1|Ubiquitin Carboxyl-terminal Hydrolase Isozyme L1|Ubiquitin Thioesterase L1|Ubiquitin Thiolesterase L1

Description

This MAb reacts with a protein of 20-30 kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1) . Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications Table·product-specifications

Related Products

Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti mouse secondary antibody
GTR00902697

Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti mouse secondary antibody

2 Units
$441.23($583.53)
Frozen Tissue Section - Alzheimer's Disease: Brain: Pituitary
GTR00904604

Frozen Tissue Section - Alzheimer's Disease: Brain: Pituitary

5 Slides
$1,328.41($1,756.82)
Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF740 conjugate, 0.1mg/mL
GTR00907161

Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF740 conjugate, 0.1mg/mL

1x 500 µL
$654.80($865.97)
Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF488A conjugate, 0.1mg/mL
GTR00910582

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF488A conjugate, 0.1mg/mL

1x 500 µL
$645.08($853.12)